9999999997-11-011004.txt : 20110603 9999999997-11-011004.hdr.sgml : 20110603 20110602171805 ACCESSION NUMBER: 9999999997-11-011004 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110603 DATE AS OF CHANGE: 20110602 20110603 20110602 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 11889379 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@ M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)= M+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]087)E;G0@."`P(%(O4F5S;W5R8V5S M(#$V(#`@4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH- M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9I/Z0Y:5NX5[_AH>Z5-5'A]VK4A.'6,#%5^ED7A>[ M9>;PU#3:;`_DOFY*5;C0HZM&-VIF<_O3.'=LTC"G@BZNWP(!8$`?@[%8-MW?L2]S[%L0L,XDV/N>#@ M']XB!T)G2(<^Q/N>`UO\CU-Y>>T1L.*_>VP(-J,L@'AB9FR/1M%ITJ:.PR)Y MR@Q>>\_D:3&/IY;MTXA,8&79`0U);%%&1K&>G9I)L/Z,[WOV@(9A<(GI#`RF M'$C,U73\M)S'8'0F.(>%Q.9DNX)P!BSS)O4M\`XAY^"A2M.4ZJ-!W00?6`;P0+_ M3(`SD7-8E!30LNUZ;NB"#>/9+^X@]%WM+77/Q$G^NO53&[$:?%T-DE&C/O\D M<^<=P^DQ43)BL&PW#)QCY#+P(=DG)FH5<(%AUNUZ;PV):!J>05)`\OK1A1;S5/\JRJO(^^NX3TMBPW2ZA&1 M\:(1DFQ&S<8<:=##95B>%BAJ'9<9C^V(FU:&IH2DA@5E9FC3GV[[#! M9&:=J#7R!>7L2+DN4O3L(7GKRI2J+"$OUYK15#G^\;1_F;`O28UF$:SBAXK7 M2(V*&L/U20WK-SAI>8@IZ1*JR,HM#Z>ZU#:[I,&+J"699;=?4=@E33K@*P?( M]S;)Q4;P&I(:9-Y,RG)\V.]YEOQUJT-?2MIL4[O;^*/`?I[IJCSG*N M-(>N2SCE';Y$PY-W5U)_)CI$M*R3V0C)5T2X):T2./!*E%D-]8&G4E/9Y\XU MA?O3?FIJ0[41;'I^%)K:@*Y4P5)%PAR*+T(6^:J0J[+=[LS*A*='(AE_]\B9 M'V$SXW*`GZSX):$H,#%P(79%[1 M-XU[_PHP`!ME\BD-"F5N9'-TFMC M.60B/SX*/'@Z>&UP;65T82!X;6QN#IX M;7!T:STB061O8F4@6$U0($-O&%P+S$N,"\B/@H@("`@("`@("`\>&UP.D-R96%T;W)4;V]L/E!38W)I M<'0U+F1L;"!697)S:6]N(#4N,BXR/"]X;7`Z0W)E871O&UL;G,Z9&,](FAT='`Z+R]P=7)L M+F]R9R]D8R]E;&5M96YT"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M(#(V-S0R M+F]R9&5R+F1O8SPO&UP34TZ26YS=&%N8V5)1#YU=6ED.F)D.#)D9#AE+61E8V0M-#=F M8BTX93,P+64X9C@U8V5C838X.#PO>&UP34TZ26YS=&%N8V5)1#X*("`@("`@ M/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#POJ'5!:DZ@F1Z#`)-6"3$Z!GVIC`( M=]6'R=%GN6N=78-$K]JPN0L]!7IB!RE@M2O0;.S9.!KUZ?058`#VHD"_#0IE M;F1S=')E86T-96YD;V)J#34@,"!O8FH-/#PO1&5C;V1E4&%R;7,\/"]#;VQU M;6YS(#0O4')E9&EC=&]R(#$R/CXO1FEL=&5R+T9L871E1&5C;V1E+TE$6SQ$ M.$8Q134V-C8V,4)&04%%-30Y0D8Y03=#,S(Q.#$W.#X\-S,V,SDW0CQ`B:>;@"P&!D8@P?0?2#`R``08 M`'I*!1L-"F5N9'-T